PepGen Inc. (PEPG)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreKey Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Dr. James G. McArthur Ph.D.
|
President, CEO, Treasurer, Secretary & Director | 1.06M | -- | 1962 |
|
Mr. Noel P. Donnelly M.B.A.
|
Chief Financial Officer | 742.6k | -- | 1970 |
|
Mr. Joseph D. Vittiglio Esq., J.D.
|
Chief Business & Legal Officer and Secretary | 391.64k | -- | 1972 |
|
Dr. Kasra Kasraian Ph.D.
|
Chief Technical Officer | -- | -- | 1967 |
|
Ms. Emiko Bryant
|
Senior Vice President of HR & Administration | -- | -- | -- |
|
Dr. Hayley Parker Ph.D.
|
Senior Vice President of Global Regulatory Affairs & Quality | -- | -- | -- |
|
Dr. Paul D. Streck M.B.A., M.D.
|
Executive VP and Head of Research & Development | 332.73k | -- | 1964 |
|
Ms. Pallavi Lonkar Ph.D.
|
Vice President & Head of Preclinical | -- | -- | -- |
|
Ms. Melissa Michaels
|
Executive Director & Head of Regulatory Affairs CMC | -- | -- | -- |
|
Mr. Michael Zhao
|
Vice President & Head of Biometrics | -- | -- | -- |
PepGen Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 57
Description
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic dystrophy type 1. It is also involved in FREEDOM-OLE, an open label expansion study. The company was founded in 2018 and is based in Boston, Massachusetts.
Corporate Governance
Upcoming Events
November 11, 2026 at 1:30 PM UTC
PepGen Inc. Earnings Date
Recent Events
May 19, 2026 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission
